475483-21-7 Usage
Uses
1. Used in Pharmaceutical Industry:
(4S,5R,6R)-5-AcetaMido-4-aMino-6-((1R,2R)-2,3-dihydroxy-1-Methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic Acid is used as an intermediate in the synthesis of Neuraminic Acid and its derivatives for the development of pharmaceutical products. The application reason is its role in the preparation of essential components for various biological processes.
2. Used in Chemical Research:
(4S,5R,6R)-5-AcetaMido-4-aMino-6-((1R,2R)-2,3-dihydroxy-1-Methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic Acid is used as a research compound in chemical laboratories for studying its properties, reactivity, and potential applications in the development of new drugs and materials. The application reason is its unique molecular structure and chemical properties that make it a valuable subject for scientific investigation.
3. Used in Biochemical Applications:
(4S,5R,6R)-5-AcetaMido-4-aMino-6-((1R,2R)-2,3-dihydroxy-1-Methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic Acid is used as a key component in the study of Neuraminic Acid and its role in various biological processes. The application reason is its direct involvement in the synthesis of Neuraminic Acid, which is crucial for understanding its functions and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 475483-21-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,5,4,8 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 475483-21:
(8*4)+(7*7)+(6*5)+(5*4)+(4*8)+(3*3)+(2*2)+(1*1)=177
177 % 10 = 7
So 475483-21-7 is a valid CAS Registry Number.
475483-21-7Relevant articles and documents
METHOD FOR PRODUCING NEURAMINIC ACID DERIVATIVE
-
, (2014/10/29)
The present invention provides methods for manufacturing neuraminic acid derivatives. [Means for solution] Methods for manufacturing compounds represented by the formula (I) : [wherein R1 represents a C1-C19 alkyl group], or a pharmacologically acceptable salt thereof, using N-acetylneuraminic acid dihydrate as a starting raw material are provided.
METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES
-
Page/Page column 66, (2008/12/08)
A method for manufacturing neuraminic acid derivatives is provided, also synthetic intermediates of the neuraminic acid derivatives and methods for their manufacture, and neuraminic acid derivatives having high purity. [Means for solution] A synthetic intermediate compound represented by the formula (7) is provided: [wherein R3 represents alkyl; R4 and R5 each represents H, alkyl, phenyl, or together represent tetramethylene, pentamethylene, oxo].